ICOTF - iCo Therapeutics Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in CAD. All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development808.534558.888592.097606.15
Selling General and Administrative664.814672.2351,619.6891,653.779
Non Recurring----
Others----
Total Operating Expenses1,473.3481,231.1232,211.7862,259.929
Operating Income or Loss-1,473.348-1,231.123-2,211.786-2,259.929
Income from Continuing Operations
Total Other Income/Expenses Net236.04-258.8416.865250.879
Earnings Before Interest and Taxes-1,473.348-1,231.123-2,211.786-2,259.929
Interest Expense----
Income Before Tax-1,237.308-1,489.923-1,794.921-2,009.05
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-1,237.308-1,489.923-1,794.921-2,009.05
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,237.308-1,489.923-1,794.921-2,009.05
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-1,237.308-1,489.923-1,794.921-2,009.05